Max Wenzel

Dr. Max Wenzel advises on a variety of matters relating to German corporate law, particularly involving domestic and cross-border M&A transactions. He also has experience counseling on compliance matters.

Dr. Wenzel’s representations since joining Skadden include:

• MorphoSys AG on its pending €2.7 billion sale to, and public takeover by, Novartis and the simultaneous disposition of the worldwide marketing rights of its antibody drug Monjuvi to Incyte Corporation
• FINN on its US$110 million Series C financing round led by Planet First Partners, with an underlying post-money valuation of more than US$650 million
• TSG Consumer Partners and Backcountry on the sale of Bergfreunde GmbH, a Germany-based online retailer of premium outdoor apparel and equipment, to DECATHLON S.E., the world’s largest sporting goods retailer
• Hermann Rosen, founder of ROSEN Group, a global leader in inspection and integrity management services for energy transmission pipelines, on the carve-out of the company’s New Ventures division, the sale of ROSEN Group to Partners Group AG and a significant reinvestment by Mr. Rosen in the new ownership structure
• Trimble on its €1.9 billion acquisition of Transporeon, a leading cloud-based transportation management software platform, from Hg